vitamin-a--pentifyllin--nicotinic-acid--and-vitamin-e-combination and Macular-Degeneration

vitamin-a--pentifyllin--nicotinic-acid--and-vitamin-e-combination has been researched along with Macular-Degeneration* in 3 studies

Trials

1 trial(s) available for vitamin-a--pentifyllin--nicotinic-acid--and-vitamin-e-combination and Macular-Degeneration

Article	Year
[Therapy of senile macular degeneration. Results of a multicenter study]. ZFA. Zeitschrift fur Allgemeinmedizin, 1982, Aug-10, Volume: 58, Issue:22 Topics: Aged; Clinical Trials as Topic; Drug Combinations; Female; Fundus Oculi; Humans; Macular Degeneration; Male; Middle Aged; Nicotinic Acids; Sex Factors; Theobromine; Vitamin A; Vitamin E	1982

Other Studies

2 other study(ies) available for vitamin-a--pentifyllin--nicotinic-acid--and-vitamin-e-combination and Macular-Degeneration

Article	Year
[Therapy of degenerative maculopathy with Cosaldon A + E]. Klinische Monatsblatter fur Augenheilkunde, 1987, Volume: 190, Issue:1 Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative maculopathy are presented (5 tables and 4 figures). Depending on the initial status up to 80% of the treated eyes responded positively to this therapy with only a small side-effect rate: these results suggest that Cosaldon A + E is a promising alternative in the treatment of degenerative maculopathy. Topics: Aged; Drug Combinations; Female; Fluorescein Angiography; Humans; Long-Term Care; Macular Degeneration; Male; Middle Aged; Nicotinic Acids; Theobromine; Visual Acuity; Visual Fields; Vitamin A; Vitamin E	1987
[Long-term treatment of senile macular degeneration with Cosaldon A+E]. Klinische Monatsblatter fur Augenheilkunde, 1985, Volume: 187, Issue:4 During the early phase of senile degeneration of the macula treatment with Cosaldon A+E offers real changes of improvement. In the later phases long-term Cosaldon therapy can bring about an appreciable improvement when other vasoactive substances are administered at intervals. The addition of the vitamins A and E improves the efficacy of Cosaldon. Results in 157 patients are supported by statistics. Topics: Adult; Aged; Drug Combinations; Drug Therapy, Combination; Female; Humans; Long-Term Care; Macular Degeneration; Male; Middle Aged; Nicotinic Acids; Theobromine; Visual Acuity; Vitamin A; Vitamin E	1985

Article

Year

[Therapy of degenerative maculopathy with Cosaldon A + E].

Klinische Monatsblatter fur Augenheilkunde, 1987, Volume: 190, Issue:1

Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative maculopathy are presented (5 tables and 4 figures). Depending on the initial status up to 80% of the treated eyes responded positively to this therapy with only a small side-effect rate: these results suggest that Cosaldon A + E is a promising alternative in the treatment of degenerative maculopathy.

Topics: Aged; Drug Combinations; Female; Fluorescein Angiography; Humans; Long-Term Care; Macular Degeneration; Male; Middle Aged; Nicotinic Acids; Theobromine; Visual Acuity; Visual Fields; Vitamin A; Vitamin E

1987

[Long-term treatment of senile macular degeneration with Cosaldon A+E].

Klinische Monatsblatter fur Augenheilkunde, 1985, Volume: 187, Issue:4

During the early phase of senile degeneration of the macula treatment with Cosaldon A+E offers real changes of improvement. In the later phases long-term Cosaldon therapy can bring about an appreciable improvement when other vasoactive substances are administered at intervals. The addition of the vitamins A and E improves the efficacy of Cosaldon. Results in 157 patients are supported by statistics.

Topics: Adult; Aged; Drug Combinations; Drug Therapy, Combination; Female; Humans; Long-Term Care; Macular Degeneration; Male; Middle Aged; Nicotinic Acids; Theobromine; Visual Acuity; Vitamin A; Vitamin E

1985